Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Avanos Medical (NYSE: AVNS) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. Michael Greiner, the company's interim chief executive officer, will deliver a presentation on Monday, January 13, at approximately 3:45 p.m. PST.
The presentation will be accessible via webcast through the Investors section of the Avanos Medical website, where it will also be archived for future reference.
Avanos Medical (NYSE: AVNS) ha annunciato la sua partecipazione alla 43ª Conferenza Annuale J.P. Morgan sulla Sanità a San Francisco. Michael Greiner, l'amministratore delegato ad interim dell'azienda, terrà una presentazione lunedì 13 gennaio, alle circa 15:45 PST.
La presentazione sarà accessibile tramite webcast nella sezione Investitori del sito web di Avanos Medical, dove sarà anche archiviata per consultazioni future.
Avanos Medical (NYSE: AVNS) ha anunciado su participación en la 43ª Conferencia Anual J.P. Morgan sobre Salud en San Francisco. Michael Greiner, el director ejecutivo interino de la empresa, dará una presentación el lunes 13 de enero, aproximadamente a las 3:45 p.m. PST.
La presentación estará disponible a través de un webcast en la sección de Inversores del sitio web de Avanos Medical, donde también se archivará para futuras referencias.
Avanos Medical (NYSE: AVNS)는 샌프란시스코에서 열리는 제43회 JP 모건 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 마이클 그레이너 회사의 임시 CEO가 1월 13일 월요일 오전 3시 45분(PST)에 발표를 진행합니다.
발표는 Avanos Medical 웹사이트의 투자자 섹션을 통해 웹캐스트로 시청할 수 있으며, 향후 참고를 위해 아카이브됩니다.
Avanos Medical (NYSE: AVNS) a annoncé sa participation à la 43ème Conférence Annuelle J.P. Morgan sur les Soins de Santé à San Francisco. Michael Greiner, le directeur général par intérim de l'entreprise, présentera une conférence le lundi 13 janvier vers 15h45 PST.
La présentation sera accessible en streaming via la section Investisseurs du site web d'Avanos Medical, où elle sera également archivée pour référence future.
Avanos Medical (NYSE: AVNS) hat seine Teilnahme an der 43. J.P. Morgan Healthcare-Konferenz in San Francisco angekündigt. Michael Greiner, der interimistische Geschäftsführer des Unternehmens, wird am Montag, den 13. Januar, um ca. 15:45 Uhr PST eine Präsentation halten.
Die Präsentation wird über einen Webcast im Bereich Investoren der Avanos Medical-Website zugänglich sein, wo sie auch für künftige Referenzen archiviert wird.
- None.
- None.
A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.
About Avanos Medical, Inc. Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302343007.html
SOURCE Avanos Medical, Inc.
FAQ
When is Avanos Medical (AVNS) presenting at the J.P. Morgan Healthcare Conference 2025?
How can investors watch the Avanos Medical (AVNS) presentation at the JP Morgan Healthcare Conference?
Who will represent Avanos Medical (AVNS) at the 2025 J.P. Morgan Healthcare Conference?
Which annual J.P. Morgan Healthcare Conference will Avanos Medical (AVNS) attend in 2025?
